✦ LIBER ✦

Clinical effects of neutralizing anti-agalsidase antibodies in patients receiving enzyme replacement therapy in the Canadian Fabry Disease Initiative Study

✍ Scribed by West, Michael; Bichet, Daniel; Casey, Robin; Clarke, Joe; Sirrs, Sandra; Aerts, Johannes; Auray-Blais, Christiane; LeMoine, Kaye

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P19—Influence of Anti-Agalsidase Antibod

✍ M. West; D. Bichet; R. Casey; J. Clarke; S. Sirrs; K. LeMoine; C. Auray-Blais 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Prospective Results of Switching Enzyme

✍ Michael West; Daniel Bichet; Robin Casey; Joe Clarke; Sandra Sirrs; Gordon Flowe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Benefit of enzyme replacement therapy in

✍ West, Michael; Bichet, Daniel; Casey, Robin; Clarke, Joe; Sirrs, Sandra; LeMoine 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Enzyme replacement therapy in a patient

✍ Tanaka, Akemi; Takeda, Taisuke; Hoshina, Takao; Fukai, Kazuyoshi; Yamano, Tsunek 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 281 KB

Effects of enzyme replacement therapy wi

✍ F Dehout; A Schwarting; M Beck; A Mehta; R Ricci; U Widmer; on behalf of the FOS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Letter concerning “Enzyme replacement th

✍ Gabor E. Linthorst; Johannes M. F. G. Aerts 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 63 KB